Clinical pharmacology of 4-demethoxydaunorubicin (DMDR)
- 1 June 1986
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 17 (2), 143-148
- https://doi.org/10.1007/bf00306743
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- PHASE-I AND PHASE-II CLINICAL AND PHARMACOLOGICAL STUDY OF 4-DEMETHOXYDAUNORUBICIN (IDARUBICIN) IN ADULT PATIENTS WITH ACUTE-LEUKEMIA1985
- Clinical pharmacology of daunorubicin in phase I patients with solid tumors: development of an analytical methodology for daunorubicin and its metabolites.1984
- Clinical pharmacology of daunorubicin in patients with acute leukemia.1984
- PHASE-I AND CLINICAL-PHARMACOLOGY STUDIES OF INTRAVENOUS AND ORAL-ADMINISTRATION OF 4-DEMETHOXYDAUNORUBICIN IN PATIENTS WITH ADVANCED CANCER1983
- Antileukemic Activity of 4-Demethoxydaunorubicin in MiceTumori Journal, 1980
- Experimental evaluation of anthracycline analogs.1979
- Comparison of Biochemical and Biological Methods in the Evaluation of New Anthracycline DrugsPublished by S. Karger AG ,1977
- SYNTHESIS AND ANTITUMOR ACTIVITY OF 4-DEMETHOXYDAUNORUBICIN, 4-DEMETHOXY-7,9-DIEPIDAUNORUBICIN, AND THEIR BETA-ANOMERS1976
- Pharmacokinetics and metabolism of adriamycin in manClinical Pharmacology & Therapeutics, 1973